CoChat

Modeling ALS and FTD with iPSC-derived neurons

Open access
Lee, Sebum, Huang, Eric J. · 2017 · Brain Research
Cited by 77

The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.

Abstract

Recent advances in genetics and neuropathology support the idea that amyotrophic lateral sclerosis (ALS) and frontotemporal lobar dementia (FTD) are two ends of a disease spectrum. Although several animal models have been developed to investigate the pathogenesis and disease progression in ALS and FTD, there are significant limitations that hamper our ability to connect these models with the neurodegenerative processes in human diseases. With the technical breakthrough in reprogramming biology, it is now possible to generate patient-specific induced pluripotent stem cells (iPSCs) and disease-relevant neuron subtypes. This review provides a comprehensive summary of studies that use iPSC-derived neurons to model ALS and FTD. We discuss the unique capabilities of iPSC-derived neurons that capture some key features of ALS and FTD, and underscore their potential roles in drug discovery. There are, however, several critical caveats that require improvements before iPSC-derived neurons can become highly effective disease models. This article is part of a Special Issue entitled SI: Exploiting human neurons.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.brainres.2015.10.003

Cites

26 of 26 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 26 references

Research works printed but not linked: 46

  1. Arambula, 2009, A simple ligand that selectively targets CUG trinucleotide repeats and inhibits MBNL protein binding, Proc. Natl. Acad. Sci. USA, 106, 16068, 10.1073/pnas.0901824106 · DOI · Paper page
  2. Ash, 2013, Unconventional translation of C9ORF72 GGGGCC expansion generates insoluble polypeptides specific to c9FTD/ALS, Neuron, 77, 639, 10.1016/j.neuron.2013.02.004 · DOI · Paper page
  3. Baumer, 2010, Juvenile ALS with basophilic inclusions is a FUS proteinopathy with FUS mutations, Neurology, 75, 611, 10.1212/WNL.0b013e3181ed9cde · DOI · Paper page
  4. Bigio, 2012, Motor neuron disease: the C9orf72 hexanucleotide repeat expansion in FTD and ALS, Nat. Rev. Neurol., 8, 249, 10.1038/nrneurol.2012.58 · DOI
  5. Burkhardt, 2013, A cellular model for sporadic ALS using patient-derived induced pluripotent stem cells, Mol. Cell Neurosci., 56, 355, 10.1016/j.mcn.2013.07.007 · DOI · Paper page
  6. Deng, 2014, The role of FUS gene variants in neurodegenerative diseases, Nat. Rev. Neurol., 10, 337, 10.1038/nrneurol.2014.78 · DOI · Paper page
  7. Devlin, 2015, Human iPSC-derived motoneurons harbouring TARDBP or C9ORF72 ALS mutations are dysfunctional despite maintaining viability, Nat. Commun., 6, 5999, 10.1038/ncomms6999 · DOI · Paper page
  8. Egawa, 2012, Drug screening for ALS using patient-specific induced pluripotent stem cells, Sci. Transl. Med., 4, 145ra104, 10.1126/scitranslmed.3004052 · DOI · Paper page
  9. Espuny-Camacho, 2013, Pyramidal neurons derived from human pluripotent stem cells integrate efficiently into mouse brain circuits in vivo, Neuron, 77, 440, 10.1016/j.neuron.2012.12.011 · DOI · Paper page
  10. Fenton, 2011, Functions and regulation of the 70kDa ribosomal S6 kinases, Int. J. Biochem. Cell Biol., 43, 47, 10.1016/j.biocel.2010.09.018 · DOI · Paper page
  11. Gendron, 2014, Mechanisms of toxicity in C9FTLD/ALS, Acta Neuropathol., 127, 359, 10.1007/s00401-013-1237-z · DOI · Paper page
  12. Goldman, 2005, Comparison of family histories in FTLD subtypes and related tauopathies, Neurology, 65, 1817, 10.1212/01.wnl.0000187068.92184.63 · DOI · Paper page
  13. Huang, 2010, Extensive FUS-immunoreactive pathology in juvenile amyotrophic lateral sclerosis with basophilic inclusions, Brain Pathol., 20, 1069, 10.1111/j.1750-3639.2010.00413.x · DOI · Paper page
  14. Jahromi, 2013, Developing bivalent ligands to target CUG triplet repeats, the causative agent of myotonic dystrophy type 1, J. Med. Chem., 56, 9471, 10.1021/jm400794z · DOI
  15. Kwiatkowski, 2009, Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis, Science, 323, 1205, 10.1126/science.1166066 · DOI · Paper page
  16. Lagier-Tourenne, 2013, Targeted degradation of sense and antisense C9orf72 RNA foci as therapy for ALS and frontotemporal degeneration, Proc. Natl. Acad. Sci. USA, 110, E4530, 10.1073/pnas.1318835110 · DOI · Paper page
  17. Lagier-Tourenne, 2010, Neurodegeneration: an expansion in ALS genetics, Nature, 466, 1052, 10.1038/4661052a · DOI
  18. Lattante, 2013, TARDBP and FUS mutations associated with amyotrophic lateral sclerosis: summary and update, Hum. Mutat., 34, 812, 10.1002/humu.22319 · DOI · Paper page
  19. Lillo, 2011, How common are behavioural changes in amyotrophic lateral sclerosis?, Amyotroph. Lateral Scler., 12, 45, 10.3109/17482968.2010.520718 · DOI · Paper page
  20. Lomen-Hoerth, 2002, The overlap of amyotrophic lateral sclerosis and frontotemporal dementia, Neurology, 59, 1077, 10.1212/WNL.59.7.1077 · DOI · Paper page
  21. Lomen-Hoerth, 2003, Are amyotrophic lateral sclerosis patients cognitively normal?, Neurology, 60, 1094, 10.1212/01.WNL.0000055861.95202.8D · DOI · Paper page
  22. Mackenzie, 2011, A harmonized classification system for FTLD-TDP pathology, Acta Neuropathol., 122, 111, 10.1007/s00401-011-0845-8 · DOI · Paper page
  23. Millecamps, 2012, Phenotype difference between ALS patients with expanded repeats in C9ORF72 and patients with mutations in other ALS-related genes, J. Med. Genet., 49, 258, 10.1136/jmedgenet-2011-100699 · DOI · Paper page
  24. Mori, 2013, The C9orf72 GGGGCC repeat is translated into aggregating dipeptide-repeat proteins in FTLD/ALS, Science, 339, 1335, 10.1126/science.1232927 · DOI · Paper page
  25. Mulders, 2009, Triplet-repeat oligonucleotide-mediated reversal of RNA toxicity in myotonic dystrophy, Proc. Natl. Acad. Sci. USA, 106, 13915, 10.1073/pnas.0905780106 · DOI · Paper page
  26. Neumann, 2006, Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis, Science, 314, 130, 10.1126/science.1134108 · DOI · Paper page
  27. Nishimura, 2014, Allele-specific knockdown of ALS-associated mutant TDP-43 in neural stem cells derived from induced pluripotent stem cells, PLoS One, 9, e91269, 10.1371/journal.pone.0091269 · DOI · Paper page
  28. Olive, 2009, TAR DNA-Binding protein 43 accumulation in protein aggregate myopathies, J. Neuropathol. Exp. Neurol., 68, 262, 10.1097/NEN.0b013e3181996d8f · DOI · Paper page
  29. Olney, 2005, The effects of executive and behavioral dysfunction on the course of ALS, Neurology, 65, 1774, 10.1212/01.wnl.0000188759.87240.8b · DOI · Paper page
  30. Ou, 1995, Cloning and characterization of a novel cellular protein, TDP-43, that binds to human immunodeficiency virus type 1 TAR DNA sequence motifs, J. Virol., 69, 3584, 10.1128/JVI.69.6.3584-3596.1995 · DOI · Paper page
  31. Qiu, 2014, ALS-associated mutation FUS-R521C causes DNA damage and RNA splicing defects, J. Clin. Invest., 124, 10.1172/JCI72723 · DOI · Paper page
  32. Raitano, 2015, Restoration of progranulin expression rescues cortical neuron generation in an induced pluripotent stem cell model of frontotemporal dementia, Stem Cell Rep., 4, 16, 10.1016/j.stemcr.2014.12.001 · DOI · Paper page
  33. Ringholz, 2005, Prevalence and patterns of cognitive impairment in sporadic ALS, Neurology, 65, 586, 10.1212/01.wnl.0000172911.39167.b6 · DOI · Paper page
  34. Sareen, 2014, Human induced pluripotent stem cells are a novel source of neural progenitor cells (iNPCs) that migrate and integrate in the rodent spinal cord, J. Comp Neurol., 522, 2707, 10.1002/cne.23578 · DOI · Paper page
  35. Sephton, 2014, Activity-dependent FUS dysregulation disrupts synaptic homeostasis, Proc. Natl. Acad. Sci. USA, 111, E4769, 10.1073/pnas.1406162111 · DOI · Paper page
  36. Strong, 2009, Consensus criteria for the diagnosis of frontotemporal cognitive and behavioural syndromes in amyotrophic lateral sclerosis, Amyotroph. Lateral Scler., 10, 131, 10.1080/17482960802654364 · DOI · Paper page
  37. Takahashi, 2007, Induction of pluripotent stem cells from adult human fibroblasts by defined factors, Cell, 131, 861, 10.1016/j.cell.2007.11.019 · DOI · Paper page
  38. Takahashi, 2006, Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors, Cell, 126, 663, 10.1016/j.cell.2006.07.024 · DOI · Paper page
  39. Toma, 2015, Motoneurons derived from induced pluripotent stem cells develop mature phenotypes typical of endogenous spinal motoneurons, J. Neurosci., 35, 1291, 10.1523/JNEUROSCI.2126-14.2015 · DOI
  40. Vance, 2009, Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6, Science, 323, 1208, 10.1126/science.1165942 · DOI · Paper page
  41. Wainger, 2014, Intrinsic membrane hyperexcitability of amyotrophic lateral sclerosis patient-derived motor neurons, Cell Rep., 7, 1, 10.1016/j.celrep.2014.03.019 · DOI · Paper page
  42. Warf, 2009, Pentamidine reverses the splicing defects associated with myotonic dystrophy, Proc. Natl. Acad. Sci. USA, 106, 18551, 10.1073/pnas.0903234106 · DOI · Paper page
  43. Wheeler, 2012, Targeting nuclear RNA for in vivo correction of myotonic dystrophy, Nature, 488, 111, 10.1038/nature11362 · DOI · Paper page
  44. Wolfe, 2009, Tau mutations in neurodegenerative diseases, J. Biol. Chem., 284, 6021, 10.1074/jbc.R800013200 · DOI · Paper page
  45. Yan, 2010, Frameshift and novel mutations in FUS in familial amyotrophic lateral sclerosis and ALS/dementia, Neurology, 75, 807, 10.1212/WNL.0b013e3181f07e0c · DOI · Paper page
  46. Yang, 2013, A small molecule screen in stem-cell-derived motor neurons identifies a kinase inhibitor as a candidate therapeutic for ALS, Cell Stem Cell, 12, 713, 10.1016/j.stem.2013.04.003 · DOI · Paper page

Cited by

See all 77

Metadata

Authors
Lee, S., & Huang, E. J.
Venue
Brain Research
Publisher
Elsevier BV
Published
2017-02
Volume
1656
Pages
88-97
ISSN
0006-8993 (ISSN-L)
OpenAlex
W1917568245
Cited by
77
References
26
FWCI
4.25
Type
journal article
Language
en
Open access
hybrid
Licence
Funders
  • National Institute of Health (OD011915)
  • Veterans Administrations BLR&D Merit Review Award (I01 BX0011-8)
  • Pilot Award (I21 BX1625)
  • Muscular Dystrophy Association (217592)
  • Consortium for Frontotemporal Dementia Research (CFR)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Modeling ALS and FTD with iPSC-derived neurons. https://app.cochat.ai/papers/10.1016/j.brainres.2015.10.003
The paper
Lee, S., & Huang, E. J. (2017). Modeling ALS and FTD with iPSC-derived neurons. Brain Research. https://doi.org/10.1016/j.brainres.2015.10.003

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.